Promising drugs keep failing in trials, and researchers have struggled to turn decades of work on amyloid, tangles, and other targets into effective treatments. An Alzheimer’s expert explains why progress has been so difficult and what new directions the field is exploring. [freakonomics.com]
Continue reading...
Continue reading...